295 related articles for article (PubMed ID: 19188446)
1. A tautomerase-null macrophage migration-inhibitory factor (MIF) gene knock-in mouse model reveals that protein interactions and not enzymatic activity mediate MIF-dependent growth regulation.
Fingerle-Rowson G; Kaleswarapu DR; Schlander C; Kabgani N; Brocks T; Reinart N; Busch R; Schütz A; Lue H; Du X; Liu A; Xiong H; Chen Y; Nemajerova A; Hallek M; Bernhagen J; Leng L; Bucala R
Mol Cell Biol; 2009 Apr; 29(7):1922-32. PubMed ID: 19188446
[TBL] [Abstract][Full Text] [Related]
2. Tautomerase Activity-Lacking of the Macrophage Migration Inhibitory Factor Alleviates the Inflammation and Insulin Tolerance in High Fat Diet-Induced Obese Mice.
Li YH; Wen K; Zhu LL; Lv SK; Cao Q; Li Q; Deng L; Chen T; Wang X; Deng KY; Wang LF; Xin HB
Front Endocrinol (Lausanne); 2020; 11():134. PubMed ID: 32265835
[TBL] [Abstract][Full Text] [Related]
3. Macrophage migration inhibitory factor enzymatic activity, lung inflammation, and cystic fibrosis.
Adamali H; Armstrong ME; McLaughlin AM; Cooke G; McKone E; Costello CM; Gallagher CG; Leng L; Baugh JA; Fingerle-Rowson G; Bucala RJ; McLoughlin P; Donnelly SC
Am J Respir Crit Care Med; 2012 Jul; 186(2):162-9. PubMed ID: 22592805
[TBL] [Abstract][Full Text] [Related]
4. Macrophage migration inhibitory factor (MIF) enzymatic activity and lung cancer.
Mawhinney L; Armstrong ME; O' Reilly C; Bucala R; Leng L; Fingerle-Rowson G; Fayne D; Keane MP; Tynan A; Maher L; Cooke G; Lloyd D; Conroy H; Donnelly SC
Mol Med; 2015 Apr; 20(1):729-35. PubMed ID: 25826675
[TBL] [Abstract][Full Text] [Related]
5. D-dopachrome tautomerase is over-expressed in pancreatic ductal adenocarcinoma and acts cooperatively with macrophage migration inhibitory factor to promote cancer growth.
Guo D; Guo J; Yao J; Jiang K; Hu J; Wang B; Liu H; Lin L; Sun W; Jiang X
Int J Cancer; 2016 Nov; 139(9):2056-67. PubMed ID: 27434219
[TBL] [Abstract][Full Text] [Related]
6. Rapid and transient activation of the ERK MAPK signalling pathway by macrophage migration inhibitory factor (MIF) and dependence on JAB1/CSN5 and Src kinase activity.
Lue H; Kapurniotu A; Fingerle-Rowson G; Roger T; Leng L; Thiele M; Calandra T; Bucala R; Bernhagen J
Cell Signal; 2006 May; 18(5):688-703. PubMed ID: 16122907
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of macrophage migration inhibitory factor (MIF) tautomerase and biological activities by acetaminophen metabolites.
Senter PD; Al-Abed Y; Metz CN; Benigni F; Mitchell RA; Chesney J; Han J; Gartner CG; Nelson SD; Todaro GJ; Bucala R
Proc Natl Acad Sci U S A; 2002 Jan; 99(1):144-9. PubMed ID: 11773615
[TBL] [Abstract][Full Text] [Related]
8. The p53-dependent effects of macrophage migration inhibitory factor revealed by gene targeting.
Fingerle-Rowson G; Petrenko O; Metz CN; Forsthuber TG; Mitchell R; Huss R; Moll U; Müller W; Bucala R
Proc Natl Acad Sci U S A; 2003 Aug; 100(16):9354-9. PubMed ID: 12878730
[TBL] [Abstract][Full Text] [Related]
9. Macrophage migration inhibitory factor (MIF) is rendered enzymatically inactive by myeloperoxidase-derived oxidants but retains its immunomodulatory function.
Dickerhof N; Schindler L; Bernhagen J; Kettle AJ; Hampton MB
Free Radic Biol Med; 2015 Dec; 89():498-511. PubMed ID: 26453918
[TBL] [Abstract][Full Text] [Related]
10. Macrophage migration inhibitory factor enhances
Tynan A; Mawhinney L; Armstrong ME; O'Reilly C; Kennedy S; Caraher E; Jülicher K; O'Dwyer D; Maher L; Schaffer K; Fabre A; McKone EF; Leng L; Bucala R; Bernhagen J; Cooke G; Donnelly SC
FASEB J; 2017 Nov; 31(11):5102-5110. PubMed ID: 28768722
[TBL] [Abstract][Full Text] [Related]
11. Macrophage migration inhibitory factor antagonizes pressure overload-induced cardiac hypertrophy.
Koga K; Kenessey A; Ojamaa K
Am J Physiol Heart Circ Physiol; 2013 Jan; 304(2):H282-93. PubMed ID: 23144312
[TBL] [Abstract][Full Text] [Related]
12. Combined Knockdown of D-dopachrome Tautomerase and Migration Inhibitory Factor Inhibits the Proliferation, Migration, and Invasion in Human Cervical Cancer.
Wang Q; Wei Y; Zhang J
Int J Gynecol Cancer; 2017 May; 27(4):634-642. PubMed ID: 28338494
[TBL] [Abstract][Full Text] [Related]
13. The critical role of macrophage migration inhibitory factor in insulin activity.
Vujicic M; Senerovic L; Nikolic I; Saksida T; Stosic-Grujicic S; Stojanovic I
Cytokine; 2014 Sep; 69(1):39-46. PubMed ID: 25022960
[TBL] [Abstract][Full Text] [Related]
14. A selective small-molecule inhibitor of macrophage migration inhibitory factor-2 (MIF-2), a MIF cytokine superfamily member, inhibits MIF-2 biological activity.
Tilstam PV; Pantouris G; Corman M; Andreoli M; Mahboubi K; Davis G; Du X; Leng L; Lolis E; Bucala R
J Biol Chem; 2019 Dec; 294(49):18522-18531. PubMed ID: 31578280
[TBL] [Abstract][Full Text] [Related]
15. Multiple binding modes of isothiocyanates that inhibit macrophage migration inhibitory factor.
Spencer ES; Dale EJ; Gommans AL; Rutledge MT; Vo CT; Nakatani Y; Gamble AB; Smith RA; Wilbanks SM; Hampton MB; Tyndall JD
Eur J Med Chem; 2015 Mar; 93():501-10. PubMed ID: 25743213
[TBL] [Abstract][Full Text] [Related]
16. Antagonism of macrophage migration inhibitory factor decreases cyclophosphamide cystitis in mice.
Vera PL; Iczkowski KA; Howard DJ; Jiang L; Meyer-Siegler KL
Neurourol Urodyn; 2010 Nov; 29(8):1451-7. PubMed ID: 20127836
[TBL] [Abstract][Full Text] [Related]
17. Regulation of MIF Enzymatic Activity by an Allosteric Site at the Central Solvent Channel.
Pantouris G; Khurana L; Ma A; Skeens E; Reiss K; Batista VS; Lisi GP; Lolis EJ
Cell Chem Biol; 2020 Jun; 27(6):740-750.e5. PubMed ID: 32433911
[TBL] [Abstract][Full Text] [Related]
18. The conformational flexibility of the carboxy terminal residues 105-114 is a key modulator of the catalytic activity and stability of macrophage migration inhibitory factor.
El-Turk F; Cascella M; Ouertatani-Sakouhi H; Narayanan RL; Leng L; Bucala R; Zweckstetter M; Rothlisberger U; Lashuel HA
Biochemistry; 2008 Oct; 47(40):10740-56. PubMed ID: 18795803
[TBL] [Abstract][Full Text] [Related]
19. Loss of macrophage migration inhibitory factor impairs the growth properties of human HeLa cervical cancer cells.
Xiao DZ; Dai B; Chen J; Luo Q; Liu XY; Lin QX; Li XH; Huang W; Yu XY
Cell Prolif; 2011 Dec; 44(6):582-90. PubMed ID: 21991924
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of MIF bioactivity by rational design of pharmacological inhibitors of MIF tautomerase activity.
Dios A; Mitchell RA; Aljabari B; Lubetsky J; O'Connor K; Liao H; Senter PD; Manogue KR; Lolis E; Metz C; Bucala R; Callaway DJ; Al-Abed Y
J Med Chem; 2002 Jun; 45(12):2410-6. PubMed ID: 12036350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
